The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, Johannes Petutschnigg et al.|European Heart Journal|2020Cited by 143
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmiasPiero Gentile, Gianfranco Sinagra, Marzia Colopi et al.|European Journal of Heart Failure|2021Cited by 40